What the Act gives you
The Companies Act 2016 sets out the basic framework for managing a Malaysian company, directors' duties, shareholder rights, meeting procedures, statutory minority remedies. It is deliberately general, designed to work for every company in the country.
The statutory minority protection of last resort sits in section 346: the oppression and unfair-prejudice remedy. It is real, but it is also reactive: a shareholder only invokes it after the harm has occurred, and it generally means litigation.
What the Act does not give you
Four areas where the statute is silent or too generic to be useful.
1. Customised roles and decision-making
The Act distributes powers between the board and the shareholders, but it does not allocate specific decisions to specific people. A founder-CEO with a hard right to appoint two directors, a CFO who must approve all capex above a threshold, an investor who insists on observer rights, none of these arrangements live in the statute. They have to be drafted.
2. Exit mechanics
The Act says little about how shareholders leave. There is no statutory drag-along, no statutory tag-along, no statutory buy-out formula. If a co-founder wants to exit, the company has to negotiate the price and the mechanism from scratch, which often happens at the worst possible moment.
3. Minority protections (beyond section 346)
Section 346 is a litigation remedy. A well-drafted SHA does the work earlier: reserved matters that need minority consent, board representation rights, information rights, anti-dilution mechanics. These keep the minority's voice in the room before the conflict becomes a court case.
4. Dilution management
The Act allows shares to be issued; it does not stop existing shareholders from being diluted on new issuances. Pre-emptive rights, rights of first refusal, and anti-dilution adjustments have to be contracted in.
The SHA and the Act work together
The point is not to displace the Act, but to fill the spaces it leaves blank. An SHA that contradicts the Act is unenforceable to that extent; an SHA that supplements the Act is what most well-run private companies actually operate by.
Drafting an SHA while everyone is aligned protects the relationship. Trying to draft one after a dispute often destroys it.
If your company does not yet have a shareholders' agreement, or your existing SHA has not been reviewed since the business changed shape, please contact us. It is far cheaper to draft properly than to argue about it later.
《公司法令》给您的
《2016 年公司法令》搭建了马来西亚公司治理的基本框架，董事义务、股东权利、会议程序、法定的小股东救济。它是有意设为一般性的，旨在覆盖国内每一家公司。
法定的最后救济，落在第 346 条: —压迫与不公允损害之救济。它是真实存在的，但属于反应式：股东须在损害发生后才能动用，且通常意味着诉讼。
《公司法令》没有给您的
以下四个领域，法律要么沉默，要么过于概括，无法直接落地。
一、量身定制的角色与决策机制
法令将权力分配在董事会与股东之间，但并未将特定决定指派给特定个人。一位拥有任命两位董事硬性权利的创办人 CEO；一位须批准所有超过一定金额资本支出的 CFO；一位坚持获得「观察员」席位的投资人，这些安排都不在法令中，必须在协议中起草。
二、退出机制
法令对股东如何退出几乎不置一词。没有法定的强制随售权，没有法定的跟随出售权，没有法定的回购公式。若一位共同创办人意欲退出，公司须从头协商价格与方式，而这往往发生在最不合时宜的时刻。
三、小股东保护（超越第 346 条）
第 346 条是诉讼救济。一份周全的股东协议则将工作前移：需要小股东同意的保留事项、董事会代表权、信息权、反稀释机制。这些条款让小股东的声音在冲突升级为诉讼前便已留在桌上。
四、稀释管理
法令允许发行新股；但并未阻止现有股东在新股发行时被稀释。优先认购权、优先购买权及反稀释调整等，必须由合同约定。
股东协议与《公司法令》并行
关键并非要取代法令，而是要填补它留下的空白。任何与法令相抵触的股东协议条款，在该范围内不可执行；而一份与法令相辅相成的股东协议，才是大多数运营良好的私人公司日常运作所依赖的真正文件。
在大家利益一致时起草股东协议，能保护关系；在纠纷发生后再起草，通常会摧毁关系。
若贵公司尚未订立股东协议，或现行股东协议已与公司目前的经营情况脱节，请与本所联系。事前完整拟定股东协议，远比日后争议处理来得划算。